Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 30.08.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
30.08.Besqab AB(publ): Strong gross margin and increased sales in Besqab's interim report for January - June 202412The interim report for January - June 2024 for Besqab AB (publ) ("Besqab") shows strong gross margin and increased sales, with a high proportion of sold homes in ongoing production. Link to the digital...
► Artikel lesen
30.08.Movinn A/S: Interim Report - H1 202412This company announcement contains inside information. 08.00 CET - Company Announcement no. 58/2024 (August 30, 2024) Continued revenue growth and improved bottom-line performance H1 2024 marks a half...
► Artikel lesen
30.08.First Hotels AB: First Hotels AB publishes interim report for the second quarter of 202417Quarterly HighlightsHalf-Year HighlightsOccupancy within Hotel Planetstaden increased by 35% compared to the same period last year, contributing to a 53% increase in RevPAR during the same period.A...
► Artikel lesen
30.08.Fnac Darty: Unieuro Issuer Statement Release And Opening Of The Tender Offer Period21Ivry-sur-Seine, France - August 29, 2024, 6:00 PM CEST THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IS NOT PERMITTED IN OR INTO THE UNITED...
► Artikel lesen
30.08.Ziccum AB: Ziccum AB (publ) Interim report Q2 202499INTERIM REPORT Q2, 1 JANUARY - 30 JUNE 2024 Significant events during Q2 2024Ziccum strengthens and streamlines business and finance functionsOn April 3, the company announced that it is reorganizing...
► Artikel lesen
30.08.Wyld Networks AB: Wyld Networks' Interim Report Q2 202423Financial Summary, Q2 2024 Q2 (April - June) January - June 2024 2023 2024 2023 Total income KSEK 2...
► Artikel lesen
30.08.Insplorion AB: Interim Report Q2 202458April - June Outcome April - JuneNet sales amounted to 160 (141) kSEKProfit after net financial items amounted to -5 376 (-7 113) kSEKBasic and diluted earnings per share: -0,23 (-0,54) SEKCash flow...
► Artikel lesen
30.08.ChromoGenics AB: ChromoGenics Interim Report January-June 2024107Key events during Q2 2024 During the first half of 2024, ChromoGenics continued its developmental journey with a strong focus on the customer and quality, continued to take measures to lower costs...
► Artikel lesen
30.08.Improved total output + residential recovery in sight, chg.: UBM released Q2 results, showing a steep ...120UBM released Q2 results, showing a steep increase in total output thanks to several disposals but still weak operating performance due to the ongoing standstill on the real estate transaction market.Total...
► Artikel lesen
30.08.Q2 in the books - SO & delisting expected for H2; chg.: S IMMO released its H1 report, showing strong ...104Topic: S IMMO released its H1 results on Wednesday evening, showing strong top line growth as well as improved operating profitability.Q2 sales increased by 15% yoy to € 186m (eNuW: € 181m), which was...
► Artikel lesen
30.08.CMS commits $100M to support ACA navigators-
30.08.Chutes and Ladders-NAHC-NHPCO Alliance's inaugural CEO; New president of IU Health Physicians-
30.08.Catalent reports upbeat Q4 results as it awaits FTC review of $16.5B sale to Novo1
30.08.Alnylam's Amvuttra turns in 'grand slam' showing in ATTR-CM, but leaves a window open for rivals-
30.08.Eli Lilly partner Hutchmed scraps China stomach cancer filing as approval seems unlikely-
30.08.Takeda taps longtime FleishmanHillard alum to head up global corporate brand and content-
30.08.Emergent's smallpox vaccine picks up FDA nod for mpox as Africa outbreak spreads1
30.08.Novo rekindles heart failure hopes for semaglutide with new pooled analysis-
30.08.UK's George Medicines posts positive results for triple-combo blood pressure drug on heels of FDA submission-
30.08.FDA approves re-expandable stent that can grow in size along with young children-
Seite:  Weiter >>